GSK plc Statistics

Total Valuation

GSK plc has a market cap or net worth of 109.04 billion. The enterprise value is 127.94 billion.

Market Cap	109.04B
Enterprise Value	127.94B

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	Feb 19, 2026

Share Statistics

Current Share Class	3.99B
Shares Outstanding	n/a
Shares Change (YoY)	-0.60%
Shares Change (QoQ)	-0.39%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	87.63%
Float	3.86B

Valuation Ratios

The trailing PE ratio is 14.17 and the forward PE ratio is 10.96.

PE Ratio	14.17
Forward PE	10.96
PS Ratio	2.48
PB Ratio	5.08
P/TBV Ratio	n/a
P/FCF Ratio	12.67
P/OCF Ratio	10.47
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.18, with an EV/FCF ratio of 14.87.

EV / Earnings	16.63
EV / Sales	2.89
EV / EBITDA	8.18
EV / EBIT	9.99
EV / FCF	14.87

Financial Position

The company has a current ratio of 0.82, with a Debt / Equity ratio of 1.11.

Current Ratio	0.82
Quick Ratio	0.50
Debt / Equity	1.11
Debt / EBITDA	1.54
Debt / FCF	2.78
Interest Coverage	14.36

Financial Efficiency

Return on equity (ROE) is 43.31% and return on invested capital (ROIC) is 26.53%.

Return on Equity (ROE)	43.31%
Return on Assets (ROA)	9.79%
Return on Invested Capital (ROIC)	26.53%
Return on Capital Employed (ROCE)	23.78%
Weighted Average Cost of Capital (WACC)	5.65%
Revenue Per Employee	657,775
Profits Per Employee	115,096
Employee Count	66,841
Asset Turnover	0.54
Inventory Turnover	1.54

Taxes

In the past 12 months, GSK plc has paid 1.50 billion in taxes.

Income Tax	1.50B
Effective Tax Rate	15.02%

Stock Price Statistics

The stock price has increased by +49.48% in the last 52 weeks. The beta is 0.35, so GSK plc's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	+49.48%
50-Day Moving Average	27.25
200-Day Moving Average	22.05
Relative Strength Index (RSI)	48.61
Average Volume (20 Days)	1,263

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GSK plc had revenue of 43.97 billion and earned 7.69 billion in profits. Earnings per share was 1.87.

Revenue	43.97B
Gross Profit	31.92B
Operating Income	12.71B
Pretax Income	9.96B
Net Income	7.69B
EBITDA	15.26B
EBIT	12.71B
Earnings Per Share (EPS)	1.87

Balance Sheet

The company has 4.60 billion in cash and 23.94 billion in debt, giving a net cash position of -19.34 billion.

Cash & Cash Equivalents	4.60B
Total Debt	23.94B
Net Cash	-19.34B
Net Cash Per Share	n/a
Equity (Book Value)	21.48B
Book Value Per Share	5.49
Working Capital	-5.22B

Cash Flow

In the last 12 months, operating cash flow was 10.42 billion and capital expenditures -1.81 billion, giving a free cash flow of 8.60 billion.

Operating Cash Flow	10.42B
Capital Expenditures	-1.81B
Depreciation & Amortization	2.55B
Net Borrowing	1.71B
Free Cash Flow	8.60B
FCF Per Share	n/a

Margins

Gross margin is 72.61%, with operating and profit margins of 28.92% and 17.50%.

Gross Margin	72.61%
Operating Margin	28.92%
Pretax Margin	22.66%
Profit Margin	17.50%
EBITDA Margin	34.70%
EBIT Margin	28.92%
FCF Margin	19.57%

Dividends & Yields

This stock pays an annual dividend of 0.88, which amounts to a dividend yield of 3.29%.

Dividend Per Share	0.88
Dividend Yield	3.29%
Dividend Growth (YoY)	14.10%
Years of Dividend Growth	2
Payout Ratio	44.86%
Buyback Yield	0.60%
Shareholder Yield	3.89%
Earnings Yield	7.06%
FCF Yield	7.89%

Dividend Details

Stock Splits

The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.

Last Split Date	Jul 19, 2022
Split Type	Reverse
Split Ratio	0.8

Scores

GSK plc has an Altman Z-Score of 2.04 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.04
Piotroski F-Score	7